About Sidero Bioscience

Sidero Mission Statement

The World Health Organization states that Iron Deficiency is the most common and widespread nutritional disorder in the world.


The Sidero mission is to provide a safe, effective, and economical remedy for iron deficiency for all peoples of the world. 

Sidero is developing novel biotherapeutics to treat gastrointestinal system disorders with significant unmet medical need.  Sidero is initially targeting the high-value Iron Deficiency market, providing one of the fastest growing investment returns in medical research.  The patented Siderosorb platform delivers a therapeutic oral iron supplement by oral ingestion in a pill, liquid, sachet or other ingestion formats.  Sidero Bioscience is the sole owner of all intellectual property.


Sidero Facilities


In addition to small research laboratory and office space located in the Hershey Center for Applied Research (HCAR, http://www.hersheyresearch.com/).  Sidero has established strong relationships with external Contract Research Organizations (CRO), Contract Manufacturing Organizations (CMO), Key Opinion Leaders (KOLs), regulatory support, and the Food and Drug Administration (FDA) to provide a solid pathway to advance BioFe™ to the market. 


The Iron Deficiency Market


The IV-Iron therapeutic market is growing rapidly and is expected to reach $1.8 Billion by 2020. 


Sidero targets the most common and widespread nutritional disorder in the world, Iron Deficiency (ID).  Iron deficiency leads to iron deficiency anemia (IDA), impedes motor and mental development in children, leading to lifelong cognitive deficiencies, and causes fatigue, reduced work capacity, and reduced quality of life in adults.  Current approaches to the treatment of iron deficiency are plainly inadequate.  Oral iron supplementation is inexpensive, however, it is ineffective in ~30% of patients and also suffers from substantial GI side effects, reducing tolerability by up to 50%.  While intravenous iron replacement therapies are generally safe and effective, they are expensive (>$2000/month) and invasive to deliver leading to both payor and patient dissatisfaction. 

Sidero seeks to address this gap by providing an affordable, more effective iron supplement with less side effects.